|
1
|
Schwartz D and Beitner R: Detachment of
the glycolytic enzymes, phosphofructokinase and aldolase, from
cytoskeleton of melanoma cells, induced by local anesthetics. Mol
Genet Metab. 69:159–164. 2000.
|
|
2
|
Scatena R, Bottoni P, Pontoglio A,
Mastrototaro L and Giardina B: Glycolytic enzyme inhibitors in
cancer treatment. Expert Opin Investig Drugs. 17:1533–1545.
2008.
|
|
3
|
Marin-Hernández A, Rodríguez-Enríquez S,
Vital-González PA, Flores-Rodríguez FL, Macías-Silva M,
Sosa-Garrocho M and Moreno-Sánchez R: Determining and understanding
the control of glycolysis in fast-growth tumor cells. Flux control
by an over-expressed but strongly product-inhibited hexokinase.
FEBS J. 273:1975–1988. 2006.
|
|
4
|
Mandard S, Zandbergen F, van Straten E,
Wahli W, Kuipers F, Muller M and Kersten S: The fasting-induced
adipose factor/angiopoietin-like protein 4 is physically associated
with lipoproteins and governs plasma lipid levels and adiposity. J
Biol Chem. 281:934–944. 2006.
|
|
5
|
Yoshida K, Shimizugawa T, Ono M and
Furukawa H: Angiopoietin-like protein 4 is a potent
hyperlipidemia-inducing factor in mice and inhibitor of lipoprotein
lipase. J Lipid Res. 43:1770–1772. 2002.
|
|
6
|
Xu A, Lam MC, Chan KW, et al:
Angiopoietin-like protein 4 decreases blood glucose and improves
glucose tolerance but induces hyperlipidemia and hepatic steatosis
in mice. Proc Natl Acad Sci USA. 102:6086–6091. 2005.
|
|
7
|
Lal A, Peters H, St Croix B, et al:
Transcriptional response to hypoxia in human tumors. J Natl Cancer
Inst. 93:1337–1343. 2001.
|
|
8
|
Le Jan S, Amy C, Cazes A, et al:
Angiopoietin-like 4 is a proangiogenic factor produced during
ischemia and in conventional renal cell carcinoma. Am J Pathol.
162:1521–1528. 2003.
|
|
9
|
Izraely S, Sagi-Assif O, Klein A, et al:
The metastatic microenvironment: brain-residing melanoma metastasis
and dormant micrometastasis. Int J Cancer. 131:1071–1082. 2012.
|
|
10
|
Sakakibara M, Takahashi I, Takasaki Y,
Mukai T and Hori K: Construction and expression of human aldolase A
and B expression plasmids in Escherichia coli host. Biochim
Biophys Acta. 1007:334–342. 1989.
|
|
11
|
Pal M, Tan MJ, Huang RL, Goh YY, Wang XL,
Tang MB and Tan NS: Angiopoietin-like 4 regulates epidermal
differentiation. PLoS One. 6:e253772011.
|
|
12
|
Costanzo P, Lupo A, Medugno L, D’Agostino
P, Zevino C and Izzo P: PKC-dependent phosphorylation of the p97
repressor regulates the transcription of aldolase A L-type
promoter. FEBS Lett. 454:61–66. 1999.
|
|
13
|
Stapleton CM, Joo JH, Kim YS, Liao G,
Panettieri RA Jr and Jetten AM: Induction of ANGPTL4 expression in
human airway smooth muscle cells by PMA through activation of PKC
and MAPK pathways. Exp Cell Res. 316:507–516. 2010.
|
|
14
|
Wu H, Yang L, Liao D, Chen Y, Wang W and
Fang J: Podocalyxin regulates astrocytoma cell invasion and
survival against temozolomide. Exp Ther Med. 5:1025–1029. 2013.
|
|
15
|
Chen X, Yang TT, Zhou Y, et al: Proteomic
profiling of osteosarcoma cells identifies ALDOA and SULT1A3 as
negative survival markers of human osteosarcoma. Mol Carcinog.
53:138–144. 2014.
|
|
16
|
Peng SY, Lai PL, Pan HW, Hsiao LP and Hsu
HC: Aberrant expression of the glycolytic enzymes aldolase B and
type II hexokinase in hepatocellular carcinoma are predictive
markers for advanced stage, early recurrence and poor prognosis.
Oncol Rep. 19:1045–1053. 2008.
|
